Cargando…

2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017

BACKGROUND: Antibiotic resistance is a cause of morbidity and mortality driven by inappropriate prescribing. In the United States, a third of all outpatient antibiotic prescriptions may be inappropriate. Seasonal influenza rates are significantly associated with antibiotic prescribing rates. The imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Eili, Schueller, Emily, Tseng, Katie K, Nandi, Arindam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810059/
http://dx.doi.org/10.1093/ofid/ofz360.2419
_version_ 1783462154592059392
author Klein, Eili
Schueller, Emily
Tseng, Katie K
Nandi, Arindam
author_facet Klein, Eili
Schueller, Emily
Tseng, Katie K
Nandi, Arindam
author_sort Klein, Eili
collection PubMed
description BACKGROUND: Antibiotic resistance is a cause of morbidity and mortality driven by inappropriate prescribing. In the United States, a third of all outpatient antibiotic prescriptions may be inappropriate. Seasonal influenza rates are significantly associated with antibiotic prescribing rates. The impact of influenza vaccination coverage on antibiotic prescribing is unknown. METHODS: We conducted a retrospective analysis of state-level vaccination coverage and antibiotic prescribing rates from 2010 to 2017. We used fixed effects regression to analyze the relationship between cumulative vaccine coverage rates for a season and the per capita number of prescriptions for systemic antibiotics for the corresponding season (January–March) controlling for temperature, poverty, healthcare infrastructure, population structure, and vaccine effectiveness. RESULTS: Rates of vaccination coverage ranged from 33% in Nevada to 52% in Rhode Island for the 2016–2017 season, while antibiotic use rates ranged from 25 prescriptions per 1,000 inhabitants in Alaska to 377 prescriptions per 1,000 inhabitants in West Virginia (Figure 1). Vaccination coverage rates were highly correlated with reduced prescribing rates, and controlling for other factors, we found that a one percent increase in the influenza vaccination rate was associated with 1.40 (95% CI: 2.22–0.57, P < 0.01) fewer antibiotic prescriptions per 1,000 inhabitants (Table 1). Increases in the vaccination coverage rate in the pediatric population (aged 0–18) had the strongest effect, followed by the elderly (aged 65+). CONCLUSION: Vaccination can reduce morbidity and mortality from seasonal influenza. Though coverage rates are far below levels necessary to generate herd immunity, we found that higher coverage rates in a state were associated with lower antibiotic prescribing rates. While the effectiveness of the vaccine varies from year to year and the factors that drive antibiotic prescribing rates are multi-factorial, these results suggest that increased vaccination coverage for influenza would have significant benefit in terms of reducing antibiotic overuse and correspondingly antibiotic resistance. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810059
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68100592019-10-28 2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017 Klein, Eili Schueller, Emily Tseng, Katie K Nandi, Arindam Open Forum Infect Dis Abstracts BACKGROUND: Antibiotic resistance is a cause of morbidity and mortality driven by inappropriate prescribing. In the United States, a third of all outpatient antibiotic prescriptions may be inappropriate. Seasonal influenza rates are significantly associated with antibiotic prescribing rates. The impact of influenza vaccination coverage on antibiotic prescribing is unknown. METHODS: We conducted a retrospective analysis of state-level vaccination coverage and antibiotic prescribing rates from 2010 to 2017. We used fixed effects regression to analyze the relationship between cumulative vaccine coverage rates for a season and the per capita number of prescriptions for systemic antibiotics for the corresponding season (January–March) controlling for temperature, poverty, healthcare infrastructure, population structure, and vaccine effectiveness. RESULTS: Rates of vaccination coverage ranged from 33% in Nevada to 52% in Rhode Island for the 2016–2017 season, while antibiotic use rates ranged from 25 prescriptions per 1,000 inhabitants in Alaska to 377 prescriptions per 1,000 inhabitants in West Virginia (Figure 1). Vaccination coverage rates were highly correlated with reduced prescribing rates, and controlling for other factors, we found that a one percent increase in the influenza vaccination rate was associated with 1.40 (95% CI: 2.22–0.57, P < 0.01) fewer antibiotic prescriptions per 1,000 inhabitants (Table 1). Increases in the vaccination coverage rate in the pediatric population (aged 0–18) had the strongest effect, followed by the elderly (aged 65+). CONCLUSION: Vaccination can reduce morbidity and mortality from seasonal influenza. Though coverage rates are far below levels necessary to generate herd immunity, we found that higher coverage rates in a state were associated with lower antibiotic prescribing rates. While the effectiveness of the vaccine varies from year to year and the factors that drive antibiotic prescribing rates are multi-factorial, these results suggest that increased vaccination coverage for influenza would have significant benefit in terms of reducing antibiotic overuse and correspondingly antibiotic resistance. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810059/ http://dx.doi.org/10.1093/ofid/ofz360.2419 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Klein, Eili
Schueller, Emily
Tseng, Katie K
Nandi, Arindam
2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
title 2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
title_full 2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
title_fullStr 2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
title_full_unstemmed 2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
title_short 2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
title_sort 2742. the impact of influenza vaccination on antibiotic use in the united states, 2010–2017
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810059/
http://dx.doi.org/10.1093/ofid/ofz360.2419
work_keys_str_mv AT kleineili 2742theimpactofinfluenzavaccinationonantibioticuseintheunitedstates20102017
AT schuelleremily 2742theimpactofinfluenzavaccinationonantibioticuseintheunitedstates20102017
AT tsengkatiek 2742theimpactofinfluenzavaccinationonantibioticuseintheunitedstates20102017
AT nandiarindam 2742theimpactofinfluenzavaccinationonantibioticuseintheunitedstates20102017